Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping

NCT05389085

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations: Dept of Dermatology Copenhagen, Denmark

View Trial Details

Completed

Fibrin Melanoma Axillary Node Study in Patients With Melanoma

NCT00504582

Conditions: Inflammation, Melanoma, Neoplasms, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma

NCT02141542

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions: Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations: UCSD Moores Cancer Center San Diego, California, United States

University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States

Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)

NCT04570722

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

NCT03548467

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations: Charité Research Organisation, Campus Benjamin Franklin Berlin, Germany

Krankenhaus Nordwest gGmbH Frankfurt, Germany

Martin-Luther-Universität Halle-Wittenberg, Universitätsklinikum Halle (Saale) Halle, Germany

University Hospital Heidelberg, NCT, Im Neuenheimer Feld 460 Heidelberg, Germany

View Trial Details

Completed

A Study of PNT2258 in Patients With Advanced Solid Tumors

NCT01191775

Conditions: Cancer, Genital Diseases, Genital Diseases, Male, +25 more
Locations: South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States

View Trial Details

Completed

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

NCT05817149

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Aalborg University Hospital Aalborg, The North Denmark Region, Denmark

View Trial Details

Completed

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

NCT01359956

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations: Not specified

View Trial Details

Completed

Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden

NCT05611229

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details